CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function

PLoS Negl Trop Dis. 2017 Feb 2;11(2):e0005329. doi: 10.1371/journal.pntd.0005329. eCollection 2017 Feb.

Abstract

Following Japanese encephalitis virus (JEV) infection neutralizing antibodies are shown to provide protection in a significant proportion of cases, but not all, suggesting additional components of immune system might also contribute to elicit protective immune response. Here we have characterized the role of T cells in offering protection in adult mice infected with JEV. Mice lacking α/β-T cells (TCRβ-null) are highly susceptible and die over 10-18 day period as compared to the wild-type (WT) mice which are resistant. This is associated with high viral load, higher mRNA levels of proinflammatory cytokines and breach in the blood-brain-barrier (BBB). Infected WT mice do not show a breach in BBB; however, in contrast to TCRβ-null, they show the presence of T cells in the brain. Using adoptive transfer of cells with specific genetic deficiencies we see that neither the presence of CD4 T cells nor cytokines such as IL-4, IL-10 or interferon-gamma have any significant role in offering protection from primary infection. In contrast, we show that CD8 T cell deficiency is more critical as absence of CD8 T cells alone increases mortality in mice infected with JEV. Further, transfer of T cells from beige mice with defects in granular lytic function into TCRβ-null mice shows poor protection implicating granule-mediated target cell lysis as an essential component for survival. In addition, for the first time we report that γ/δ-T cells also make significant contribution to confer protection from JEV infection. Our data show that effector CD8 T cells play a protective role during primary infection possibly by preventing the breach in BBB and neuronal damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Encephalitis Virus, Japanese / genetics
  • Encephalitis Virus, Japanese / physiology*
  • Encephalitis, Japanese / immunology*
  • Encephalitis, Japanese / mortality*
  • Encephalitis, Japanese / prevention & control
  • Encephalitis, Japanese / virology
  • Female
  • Humans
  • Interferon-gamma / immunology
  • Interleukin-10 / immunology
  • Interleukin-4 / immunology
  • Male
  • Mice
  • Mice, Inbred C57BL

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Interleukin-10
  • Interleukin-4
  • Interferon-gamma

Grants and funding

National Institute of Immunology and Translational Health Sciences and Technology Institute received core funding from the Department of Biotechnology, Ministry of Science and Technology, Government of India. Extramural funding from the Department of Biotechnology, Ministry of Science and Technology, Government of India (AG SR VB) and Science and Engineering Research Board, Ministry of Science and Technology, Government of India (AG SR VB) was available. Research Fellowships from Council for Scientific and Industrial Research, Government of India (NJ NO), and post-doctoral fellowship in the form of Vaccine Research Innovation Award (TA) were availed. Funding from Wellcome Trust-DBT Alliance is available to GRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.